337 related articles for article (PubMed ID: 6248208)
1. Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.
Teulings FA; van Gilse HA; Henkelman MS; Portengen H; Alexieva-Figusch J
Cancer Res; 1980 Jul; 40(7):2557-61. PubMed ID: 6248208
[TBL] [Abstract][Full Text] [Related]
2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
3. Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
Cancer Treat Rep; 1978 Sep; 62(9):1281-6. PubMed ID: 688273
[TBL] [Abstract][Full Text] [Related]
4. The influence of progestins on receptor levels in breast cancer metastasis.
Lundgren S; Kvinnsland S; Varhaug JE; Utaaker E
Anticancer Res; 1987; 7(1):119-23. PubMed ID: 3032071
[TBL] [Abstract][Full Text] [Related]
5. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
Smith RA; Lea RA; Weinstein SR; Griffiths LR
Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
[TBL] [Abstract][Full Text] [Related]
6. Improved measurement of androgen receptors in human breast cancer.
Lea OA; Kvinnsland S; Thorsen T
Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
8. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
9. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
10. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
11. [Hormone dependence and the basis of hormone therapy in breast cancer].
Martin PM
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):183-99. PubMed ID: 209076
[No Abstract] [Full Text] [Related]
12. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
13. Progestins in the menopause in healthy women and breast cancer patients.
Pasqualini JR
Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
[TBL] [Abstract][Full Text] [Related]
14. Steroid receptor analyses of nine human breast cancer cell lines.
Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
[TBL] [Abstract][Full Text] [Related]
15. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate.
Buchanan G; Birrell SN; Peters AA; Bianco-Miotto T; Ramsay K; Cops EJ; Yang M; Harris JM; Simila HA; Moore NL; Bentel JM; Ricciardelli C; Horsfall DJ; Butler LM; Tilley WD
Cancer Res; 2005 Sep; 65(18):8487-96. PubMed ID: 16166329
[TBL] [Abstract][Full Text] [Related]
16. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
[TBL] [Abstract][Full Text] [Related]
17. Hormonal receptors in human neoplasia.
Sandberg AA; Karr JP
Int Adv Surg Oncol; 1980; 3():311-50. PubMed ID: 6256296
[No Abstract] [Full Text] [Related]
18. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
19. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
20. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]